Newborn screening for SCID: where are we now?

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a group of rare genetic disorders that affect the immune system.
• Early detection and treatment of SCID are crucial for survival.
• Newborn screening (NBS) offers a promising approach for identifying infants with SCID.

Purpose of the Study:

• To review the rationale for including SCID in NBS programs.
• To analyze the outcomes of SCID NBS over the first six years.
• To discuss challenges in screening and managing infants detected through NBS.

Main Methods:

• Review of existing literature and screening program data.
• Analysis of T-cell receptor excision circle (TREC) assay performance.
• Examination of clinical outcomes and management strategies for screened infants.

Main Results:

• SCID is a suitable condition for NBS due to its severity and treatability.
• TREC assay has demonstrated effectiveness in identifying SCID cases.
• Screening has led to earlier diagnosis and improved outcomes for affected infants.

Conclusions:

• NBS for SCID is a valuable public health initiative.
• Ongoing challenges in screening and management require further attention.
• The future of NBS for primary immunodeficiencies holds significant promise.